TRAT1
T-cell receptor-associated transmembrane adapter 1
Also known as: HSPC062, TCRIM, TRAT1_HUMAN, TRIM
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6PIZ9
- Gene
- TRAT1
- Ensembl
- ENSG00000163519
- Chromosome
- 3
- Canonical length
- 186 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Plasma membrane,Mitotic spindle,Centriolar satellite
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Predicted to enable transmembrane receptor protein tyrosine kinase adaptor activity. Acts upstream of or within negative regulation of receptor recycling; negative regulation of transport; and positive regulation of signal transduction. Located in centriolar satellite; mitotic spindle; and plasma membrane. Part of T cell receptor complex. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
186 residues, UniProt reviewed canonical sequence.
>Q6PIZ9|TRAT1
1 MSGISGCPFF LWGLLALLGL ALVISLIFNI SHYVEKQRQD KMYSYSSDHT RVDEYYIEDT
61 PIYGNLDDMI SEPMDENCYE QMKARPEKSV NKMQEATPSA QATNETQMCY ASLDHSVKGK
121 RRKPRKQNTH FSDKDGDEQL HAIDASVSKT TLVDSFSPES QAVEENIHDD PIRLFGLIRA
181 KREPINLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TRAT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.65
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- thymus: 74 nTPM
- lymph node: 22 nTPM
- tonsil: 12 nTPM
- appendix: 10 nTPM
- spleen: 8 nTPM
- small intestine: 2.8 nTPM
Single-cell type
- t-cells: 145 nCPM
- thymocytes: 53 nCPM
- nk-cells: 42 nCPM
- innate lymphoid cells: 24 nCPM
- cone photoreceptor cells: 19 nCPM
- conjunctival goblet cells: 3.9 nCPM
Immune cell
- basophil: 397 nTPM
- naive CD4 T-cell: 314 nTPM
- memory CD4 T-cell: 230 nTPM
- total PBMC: 139 nTPM
- memory CD8 T-cell: 120 nTPM
- MAIT T-cell: 117 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- basal ganglia: 0.1 nTPM
- choroid plexus: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
- pons: 0.1 nTPM
- spinal cord: 0.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.78
- gnomAD pLI
- 0.06
- gnomAD missense Z
- -0.36
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- cellular defense response
- negative regulation of receptor recycling
- negative regulation of transport
- positive regulation of calcium-mediated signaling
- positive regulation of T cell receptor signaling pathway
- signal transduction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SHP2-interacting transmembrane adaptor protein, SIT
- T-cell receptor-associated transmembrane adapter 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TRAT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TRAT1 as an antibody target. Whether an autoantibody or antibody against TRAT1 could matter depends on whether native TRAT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TRAT1 is annotated at the cell surface, where native TRAT1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TRAT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...